The order commits at least $50 million in federal funds to boost research on ibogaine, a powerful hallucinogen.

The President has cleared the way for research into new mental-health treatments - but experts urge caution

Clinical trials using psychedelic drugs could soon take place with the help of Louisiana’s Department of Health under legislation that has passed the state Senate.

A new executive order signed by President Donald Trump is speeding up research into psychedelics as a treatment for serious mental health conditions.

President Donald Trump on Saturday signed an executive order aimed at encouraging expanded research into ibogaine and other psychedelic drugs, part of a broader push to explore emerging mental health treatments.

April 20 (Reuters) - Shares of psychedelic drug developers rose in premarket trading on Monday after U.S. President Donald Trump signed an executive order directing health regulators to speed up reviews of psychedelic drugs and boosted federal research funding.

Colorado voters have passed a ballot initiative to decriminalize psychedelic mushrooms (Photo: MGN Online) CBS News — Colorado regulators are issuing licenses for providing psychedelic mushrooms and are planning to authorize the state’s first ...